Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Merkel Cell Carcinoma cN2 TNM Finding v7	NCIT_C88546	[Merkel cell carcinoma in transit metastasis. In transit metastasis is defined as a tumor distinct from the primary lesion and located either (1) between the primary lesion and the draining regional lymph nodes or (2) distal to the primary lesion. (from AJCC 7th Ed.)]
Voltage-Gated Potassium Ion Channel Activation	NCIT_C88550	[A process that involves detection of alteration to the voltage across a membrane, and results in opening of the channel to become selectively permeable to potassium ions. This interaction plays a crucial role in setting the potential of the resting membrane.]
Voltage-Gated Sodium Ion Channel Activation	NCIT_C88551	[A process that involves detection of alteration to the voltage across a membrane, and results in opening of the channel to become selectively permeable to sodium ions. This interaction plays a key role in conduction of nerve impulses throughout the central and peripheral nervous systems. Deficiencies in this process may result in various channelopathies, featuring epilepsy, seizures and paralysis.]
Merkel Cell Carcinoma cM1a TNM Finding v7	NCIT_C88553	[Merkel cell carcinoma with metastasis to skin, subcutaneous tissues or distant lymph nodes. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT4b TNM Finding v7	NCIT_C88598	[Carcinoma of the conjunctiva with tumor invading bone. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT4 TNM Finding v7	NCIT_C88596	[Carcinoma of the conjunctiva with tumor invading the orbit with or without further extension. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT4c TNM Finding v7	NCIT_C88599	[Carcinoma of the conjunctiva with tumor invading adjacent paranasal sinuses. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva Pathologic TNM Finding v7	NCIT_C88587	[A pathologic finding about one or more characteristics of carcinoma of the conjunctiva, following the rules of the TNM AJCC v7 classification system. Complete resection of the primary site is indicated (if possible). The specimen should be thoroughly sampled for histologic study of surgical margins, type of tumor, and grade of malignancy. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva Pathologic Primary Tumor TNM Finding v7	NCIT_C88588	[A pathologic finding about one or more characteristics of carcinoma of the conjunctiva, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor.]
Carcinoma of the Conjunctiva pTX TNM Finding v7	NCIT_C88589	[Carcinoma of the conjunctiva in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)]
Benralizumab	NCIT_C88594	[An afucosylated, humanized monoclonal antibody against the alpha chain of the interleukin-5 receptor (IL-5Ra), with potential anti-asthmatic activity. Upon administration, benralizumab binds to IL-5Ra and elicits an antibody-directed cell cytotoxicity (ADCC) against IL-5Ra-expressing cells. This induces apoptosis in IL-5Ra-expressing cells and may reduce asthmatic episodes. IL-5Ra, expressed on both eosinophils and basophils, plays a key role in asthma.]
Carcinoma of the Conjunctiva pT3 TNM Finding v7	NCIT_C88595	[Carcinoma of the conjunctiva with tumor invading adjacent structures (excluding the orbit). Adjacent structures include the cornea (3, 6, 9, or 12 clock hours), intraocular compartments, forniceal conjunctiva (lower and/or upper), palpebral conjunctiva (lower and/or upper), tarsal conjunctiva (lower and/or upper), lacrimal punctum and canaliculi (lower and/or upper), plica, caruncle, posterior eyelid lamella, anterior eyelid lamella, and/or eyelid margin (lower and/or upper). (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT4a TNM Finding v7	NCIT_C88597	[Carcinoma of the conjunctiva with tumor invading the orbital soft tissues, without bone invasion. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT0 TNM Finding v7	NCIT_C88590	[Carcinoma of the conjunctiva with no evidence of a primary tumor. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pTis TNM Finding v7	NCIT_C88591	[Carcinoma of the conjunctiva with a finding of carcinoma in situ. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT1 TNM Finding v7	NCIT_C88592	[Carcinoma of the conjunctiva with tumor measuring 5 mm or less in greatest dimension. Note: tumors occur most commonly in the bulbar limbal conjunctiva. (from AJCC 7th Ed.)]
Carcinoma of the Conjunctiva pT2 TNM Finding v7	NCIT_C88593	[Carcinoma of the conjunctiva with tumor measuring more than 5 mm in greatest dimension without invasion of adjacent structures. Adjacent structures include the cornea (3, 6, 9, or 12 clock hours), intraocular compartments, forniceal conjunctiva (lower and/or upper), palpebral conjunctiva (lower and/or upper), tarsal conjunctiva (lower and/or upper), lacrimal punctum and canaliculi (lower and/or upper), plica, caruncle, posterior eyelid lamella, anterior eyelid lamella, and/or eyelid margin (lower and/or upper). (from AJCC 7th Ed.)]
Platelet Activating Factor Degradation	NCIT_C40679	[Platelet Activating Factor Degradation consists of conjugation, transport, and/or oxidation of a phospholipid derivative (platelet activating factor) formed by platelets, basophils, neutrophils, monocytes, and macrophages that acts as a potent agent of platelet aggregation, inflammation, neutrophil activity, prostaglandin synthesis, and systemic anaphylaxis: hypotension, thrombocytopenia, neutropenia, and bronchoconstriction.]
Melanoma of the Conjunctiva TNM Finding v7	NCIT_C88613	[A finding about one or more characteristics of melanoma of the conjunctiva, following the rules of the TNM AJCC v7 classification system. No stage grouping is presently recommended for melanoma of the conjunctiva. (from AJCC 7th Ed.)]
SGRQ Past 3 Months Version - Short of Breath When Bend Over	NCIT_C112648	[St. George's Respiratory Questionnaire Past 3 Months Version (SGRQ Past 3 Months Version) These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over.]